INTRODUCTION
More than 20 years have passed since the discovery of natural covalent complexes of nucleic acids and proteins (1) (2) (3) (4) (5) . Covalent complexes of nucleic acids and proteins are both stable and highly specific because they are nucleoproteins linked by a unique covalent bond. Two important properties are associated with these complexes: (i) a novel structure, describing a new class of natural nucleoproteins; (ii) specific functions, that have led to an understanding of previously undiscovered mechanisms of DNA and RNA replication (i.e. the protein priming mechanism) and that are ultimately needed to change the topology of DNA, for DNA integration, conjugation, DNA structure resolution and other as yet unknown functions. Due to availability and the ability to obtain homogeneous preparations, the majority of data on structure and function have been obtained with covalent nucleic acid and protein complexes of viral origin.
HISTORY
Covalent binding of polypeptides to nucleic acids was originally discovered following isolation of high molecular weight viral, bacterial or eukaryotic nucleic acids. Trace amounts (0.1-0.3% by mass) of material composed of amino acids were found in nucleic acid preparations even after protease treatment and SDS-phenol extraction. Thus it is estimated that as many as 100 polypeptide moieties might be bound to one molecule of eukaryotic chromosomal DNA via an internucleotide phosphate linkage. Based on the stability of isolated nucleotide-peptides in alkaline solution, polypeptide binding to internucleotide phosphate groups via a phosphoamide bond was proposed (6,7) more than 20 years ago. At that time, no data on the alkali stability of tyrosine and nucleotide phosphoesters were available.
Subsequently, the phosphotriester character of DNA-peptide covalent complexes was demonstrated (8) . This kind of interpolymeric linkage has to attenuate adjacent internucleotide bonds and might lead to an apparent molecular mass decrease during DNA isolation.
The discovery of phosphoserine in DNA hydrolysis products (9, 10) and the correlation between content of 'residual' peptides and proliferation of the cell (11) generated much speculation on the functions of such complexes. For example, a structure of chromosomal DNA with subunits of DNA linked to each other via peptide bridges was proposed (9) . This model of bacterial chromosomal DNA organization was examined and refuted (7) . The initial findings that suggested the existence of nucleic acid-protein complexes also spurred the synthesis and study of hydrolytic properties of a variety of model compounds (12) (13) (14) (15) .
The shortcomings of these original studies of natural complexes included lack of a complete chemical structure of the nucleic acid-protein covalent linkage unit and absence of the molecular and functional characteristics of the protein constituents. These deficiencies were partially overcome by J.Wang's attractive proposal to explain how topoisomerase (Topo) could change the topology of supercoiled DNAs. He hypothesized the introduction of a nick in the DNA helix by a nicking-closing enzyme and formation of a transient covalent DNA-Topo I complex active in restoration of the internucleotide bond (16) . Later, formation and disjoining of the active covalent compound of φX174 phage DNA and A protein during initiation-termination of DNA replication and segregation of parent and progeny genomes was illustrated in detail (17) . To date, a covalent character of the interpolymeric bond has been proposed for a large number of viral nucleic acid-protein complexes (reviewed in [18] [19] [20] [21] [22] . In many cases, these proposals have been confirmed.
The latest progress in structural analysis of these covalent complexes was obtained by X-ray diffraction study of DNA-protein crystals, as well as refinement of the chemical mechanisms leading to covalent complex formation (23, 24) .
ISOLATION AND STRUCTURAL ANALYSIS OF NUCLEIC ACID-PROTEIN COMPLEXES TO DEMONSTRATE THE COVALENT NATURE OF THE LINKAGE
We have determined the chemical structure of the interpolymeric covalent bonds of five nucleic acid-protein covalent complexes from bacteriophage (25, 26) , viruses (27) (28) (29) and cells (30) . To unequivocally prove covalent binding of the protein to the nucleic acid in the complex, biochemical structural analysis is required. Some practical comments on these structural studies are given below.
Resistance to chaotropic agent treatment does not adequately prove the covalent nature of an interpolymeric bond formed in a high molecular weight, naturally occurring complex. There are reports that some cellular non-covalent nucleic acid-protein complexes tolerate proteinase K + SDS + phenol treatment (8) . The complex formed by biotin and avidin is stable even at high pH and on exposure to protein denaturing agents, proteolytic enzymes and organic solvents. Phenol + SDS treatment seems to be the most powerful method for removing proteins from nucleoproteins. However, it is important to remember that both of these 'one-of-a-kind' constituents of the complex protect each other from dissociation and enzyme digestion and that the distribution of proteins during phenol treatment of nucleoproteins depends on the coefficient of extraction (distribution) of the individual protein. For example, the strongly acidic protein prothymosin α partitions to the aqueous phase quantitatively during phenol extraction (31) . Some bacterial glycopeptide structures also remain in the aqueous phase after SDS + phenol extraction (32) .
Natural covalent complexes of nucleic acids and proteins are often available only in picomolar quantities. Thus radioactive labelling of the complex under study to high specific activities is necessary. All covalent complexes examined so far are phosphoesters of nucleic acids and proteins. To label the nucleic acid in the complex in vivo, radioactive orthophosphate is favoured, because both constituents share a common phosphate group which occupies a central position in the linkage unit. It is significant that the specific radioactivity of the complex must be >200 c.p.m./nucleotide phosphate to identify the O-phosphoamino acid residue after acid hydrolysis. To achieve the appropriate level of incorporation of 32 P into the complexes, mammalian cells are cultivated in a low phosphate medium (usually <25 µM) in the presence of up to 250 µCi/ml radioactive phosphate. Labelling of the covalent linkage unit in a complex with a 3 H-or 14 C-labelled nucleoside is also helpful. It should be mentioned that RNA labelling in vivo with H]uridine has the advantage over H]uridine because the hydrogen atom at C6 in uridine exchanges much more slowly with water than does the C5 hydrogen atom, particularly under conditions of complete acid hydrolysis of the core nucleotidepeptide (33) .
The protein moiety of the complex must be labelled with hydrophobic amino acids which are not included in vivo in nucleic acids and are chemically stable, i.e. Val, Ile, Leu, Phe, Tyr, and Met. Finally, the protein part of the covalent complex can be specifically labelled in vitro to high specific activity, for example with radioactive iodine. The highest incorporation of radioactivity was obtained after selective acylation of the NH 2 group of the protein (peptide) moiety in the nucleoprotein (34) by unlabeled β-(4-hydroxyphenyl)propionic acid N-hydroxysuccinimide ester and subsequent iodination of 4-hydroxyphenyl, tyrosine and histidine residues by the Na 125 I/chloramine T procedure (35) .
In general, the structural analysis consists of three stages:
(i) Isolation of the complex by deproteinization with phenol + SDS. To prevent loss of the covalent complex during the first deproteinization step, the concentration of the complex should be held at a moderate level. At a concentration of nucleic acid >1 mg/ml, a portion of the complex often partitions to the interface between the aqueous and organic phases of the extraction solution. Extraction of the first interface with a small volume of slightly alkaline buffer containing 0.1-0.2% SDS increases recovery of the complex. Generally, after four repeated extractions, the change in the quantity of protein bound tightly to nucleic acids is insignificant. Additional precipitation of the RNA-protein covalent complex with 2 M LiCl is also useful.
(ii) Exhaustive hydrolysis of the complex to produce the smallest and most homogeneous nucleotide-peptide containing the linkage unit. Isolation of the nucleotide-peptide from the initial complex is a key step in structural analysis because it consists of the covalent linkage unit in which nucleotide and amino acid residues are bound directly to one another. Two strategies for hydrolysis of covalent nucleic acid-protein complexes to produce a nucleotidepeptide core have been used. These include first digesting the nucleic acid constituent of the complex and then hydrolysing the protein component. The second strategy merely reverses the order of hydrolysis. Following either of these two pathways, the molecular characteristics of the protein or the nucleic acid can then be determined. Usually proteinase K treatment (2 mg/ml for several hours) is used to achieve limited digestion of the protein moiety. Proteolytic digestion of the complex should be carried out in SDS (0.1-0.5%) and EDTA (1-5 mM) to prevent non-specific hydrolysis of the nucleic acid component. In practice, exhaustive hydrolysis of RNA in the complex is accomplished using non-specific endonuclease P1 or S1 and RNase T2 or Pb2. Treatment of the complex with RNases A and T1 is also productive. This largely results in a nucleoside diphosphate covalently linked to protein because the interpolymeric phosphodiester bond is resistant to RNases. Complete hydrolysis of DNA presents a real challenge to structural analysis because there is no single nuclease capable of digesting double-stranded DNA into mononucleotides. DNase I and exonucleases are mostly used in sequential steps to hydrolyse DNA. Resistance to 4 M urea, 0.1% SDS and 15% phenol favours benzonase for identification of proteins tightly bound to chromosomal DNA (36).
(iii) Identification of nucleotide and amino acid residues directly bound to one another in the initial complex and determination of the chemical structure of the covalent bond. As mentioned above, the core nucleotide-peptide contains a linkage unit where the phosphate group is shared by nucleotide and amino acid residues. In the majority of DNA complexes, except for eukaryotic Topo I and Int family recombinases and vaccinia virus type I topoisomerase (37) (38) (39) (40) , proteins are bound to the 5′-end phosphate group of a nucleotide. Hydrolysis of the interpolymeric linkage unit with SVE (for 5′ P→O derivatives) or spleen phosphodiesterase (for 3′ P→O derivatives) proves the phosphodiester character of the bond between nucleic acid and protein in the natural complex. In addition, it allows identification of the nucleotide residue directly involved in binding by paper or cellulose thin layer electrophoresis and/or by ion exchange TLC on DEAE-or polyethyleniminocellulose. In some cases, digestion of the core nucleopeptide with micrococcal nuclease appeared informative for determination of its chemical structure. If the linkage unit consists of a nucleoside diphosphate and a hydroxyamino acid residue, a 3′-nucleotide and O-phosphoamino acid are produced.
To identify amino acids involved in the phosphodiester linkage, hydrolysis with a mixture of trifluoroacetic and hydrochloric acids (2:1 v/v, 20-30 min, 165_C) is the best choice. The yield of O-phosphoamino acids is in the range 11-16% (25, 26, 29, 30) , good enough for their identification by chromatography or electrophoresis methods. It is important to keep in mind that during paper electrophoresis at pH 3.5 pTyr and pU move together. Thus electrophoretic separation at pH 1.7-1.9 is preferred (28) .
SOME COMMENTS ON STRUCTURAL ANALYSIS
Until enzymes or chemical agents are identified which specifically hydrolyse the interpolymeric bond in the covalent complex, the above-described structural analysis schemes (or variants thereof) need to be employed. In this context, the hydrolytic properties of model nucleotide-peptides and activities of the 'unlinking' enzymes, which specifically hydrolyse interpolymeric phosphodiester bonds, are considered below.
HYDROLYTIC PROPERTIES OF THE MODEL NUCLEOTIDE-PEPTIDES
Hydrolysis of phosphoamide and phosphodiester synthetic derivatives of nucleotides and amino acids (peptides) was thoroughly examined by Z.A.Shabarova and co-workers in the 1960s-1970s (reviewed in 12) and was continued by B.A.Juodka's laboratory (14, 15) . A brief summary of selected data important for structural analysis of covalent nucleic acid-protein complexes is presented below.
In general, lengthening of the peptide and nucleotide moieties in model compounds stabilizes phosphodiester derivatives against hydrolysis by both acid and alkali. Acid hydrolysis of hydroxyamino acids and nucleotide phosphodiester compounds occurs under severe conditions (pH <1). In alkali, tyrosine derivatives are much more stable than serine and threonine derivatives. When considering the stability or lability to hydrolysis of the bond formed between nucleic acid and protein, one important point is the influence of protein (peptide) functional groups proximal to this bond. In the course of treatment of natural nucleic acid-protein complexes with alkali, amino groups, present in positions proximal to the phosphodiester bond formed both by serine and threonine peptides, can trigger chemical rearrangements involving the interpolymeric covalent bonds. If the amino group of serine or threonine peptides is substituted, for example by an (amino)acyl group, β-elimination at the α-carbon atom of the hydroxyamino acid residue in alkaline conditions takes place at a faster rate than hydrolysis of the interpolymeric phosphodiester bond. Appearance of a double bond in α-aminoacrylic acid (in the case of Ser) or in α-aminocrotonic acid (in the case of Thr) can be detected by absorption at 241 nm. Alternatively, radioactive reagents (Na 35 SO 3 and 14 CH 3 NH 2 , for example) added specifically to the double bond may be used. A free carboxyl group located near the linkage unit suppresses this β-elimination reaction.
Recently, a 'chemical' approach based on β-elimination of VPg (viral protein genome-linked) from nepovirus RNA was successfully used to identify an N-substituted serine residue involved in the covalent linkage (41) . In this study, the β-elimination reaction could proceed with any serine residue of VPg except the N-terminal one. If the amino group of Ser or Thr is free, O→N acyl migration from the RNA 5′-end nucleotide to the adjacent NH 2 group takes place under alkaline conditions, i.e. a P→O bond is converted to a P→N bond.
'UNLINKING' ENZYMES
The 5′-end uridylic acid of virion (1,2,27) and replicating (42, 43) , but not polysomal, picornavirus RNA (44,45) is linked with the virus polypeptide VPg by a phosphodiester bond via a unique tyrosine residue. An 'unlinking' enzyme activity, specifically hydrolysing the interpolymeric phosphodiester bond, was discovered in animal and plant cells using picornavirus RNA-VPg complexes as substrates (46) (47) (48) (49) (50) (51) . Several possible functions of the RNA unlinking enzyme which were raised included triggering of picornaviral RNA translation and regulation of viral RNA encapsidation or RNA replication (46) (47) (48) (49) . These have not yet been proved.
An enzyme preparation obtained from HeLa cells was enriched with a protein with a molecular mass of 29 kDa, however, the low turnover rate makes its classificaiton as an enzyme problematical (47) .
The substrate specificity of the 'unlinking' enzyme isolated from ascites Krebs II cells using picorna and comovirus RNA-VPgs, EMC virus RNA-VPg derivatives and synthetic models (34, 52 ) is under examination in our laboratory. We have developed new efficient substrates (34, 51) and methods for enzyme activity determination (51) to obtain biochemical enzyme characteristics (34, (51) (52) (53) . Briefly, the enzyme is an acidic protein (pI 4.6-5.0) (34, 53) . It exists in cell lysates in a complex with nucleic acids resistant to dissociation up to 200 mM KCl (53) . Antibodies against the N-terminal dodecapeptide of EMCV VPg do not inhibit the unlinking enzyme. These results suggest that the unlinking enzyme recognizes the nucleic acid constituent of the substrate. The enzyme is active in 0.5-5 mM Mg 2+ . The maximum enzyme activity is in the range 50-200 mM KCl, pH 5.2-8.0 and 5 mM 2-mercaptoethanol. The enzyme is stable at pH 4.0, it is inactivated at 55_C and it is inhibited by Ca 2+ and Zn 2+ at concentrations >1 mM or by 100 mM NH 4 + and 20% acetonitrile.
Further, the unlinking enzyme does not hydrolyse synthetic phosphodiesters between tyrosine and uridylic acid or tyrosine and d(TCTCTCCTCTTCCCTCC) (34) . Tyr-pT 13 C 2 , pT 13 C 2 , T 13 C 2 , Cl-phenoxy-pT 13 C 2 , CH 3 O-pT 13 C 2 , when added to the substrate in 10-fold molar excess, had little or no effect on the enzyme reaction (G.Shatskaya, personal communication). 'Unlinking' enzyme hydrolyses picornavirus and comovirus (here VPg is bound to RNA via serine residue; 29) RNA-VPg substrates differently (52, 54) . Keeping in mind these findings, we tentatively named the unlinking enzyme uridilylpolynucleotide-(5′→O)-tyrosine phosphodiesterase (Y-pUpN PDE) (51) .
We suggest the following conclusions: (i) it appears that a new class of cell hydrolases has been found; (ii) since viral substrates are foreign to non-infected cells, eukaryotic cells harbour unknown covalent complexes of cellular RNA and proteins structurally similar to the picornaviral ones.
To determine the role of the unlinking enzyme in picornavirus infection and to discover its cellular targets, we obtained antiserum against the EMC virus RNA-VPg complex. A fraction of antibodies which recognized the covalent linkage unit in either the EMC virus RNA-VPg or in synthetic N-AcTyr(O-pU-2′-NH 2 )OEt and N-Ac-Tyr(O-pT 13 C 2 )OEt was found and partially purified (55) . This finding offers promise for using the picornavirus RNA-VPg or synthetic models, mimicking the covalent linkage unit, as picornaviral vaccines.
Recently, an enzyme which cleaves the covalent bond between DNA and Topo I in a dead-end complex was found (56) . The DNA unlinking enzyme is presumably involved in repair of DNA which is impaired by dead-end covalent complex formation between Topo I and DNA. Hydrolysing the interpolymer phosphodiester bond, this enzyme releases Topo I from the covalent complex and generates a free phosphate group, thus restoring the regular DNA sugar-phosphate backbone.
It is vital to note that human Topo I is the sole target of the campthotecin (CPT) family of anticancer drugs. In the presence of the drug, the dead-end product described above forms. One can speculate that the DNA-Topo I unlinking enzyme might interfere with CPT therapy, breaking the complex, restoring the function of DNA and diminishing the therapeutic effect of the drug. Thus, poisoning of the DNA unlinking enzyme may be desirable for efficient therapy.
CLASSIFICATION OF NATURAL COVALENT COMPLEXES OF NUCLEIC ACIDS AND PROTEINS
Currently available data suggest that proteins involved in nucleic acid-protein complexes can be divided into two classes according to their properties. Features specific to the two classes of proteins and their respective complexes are listed below.
Class I
These proteins form covalent complexes with a nucleic acid through nucleophilic attack by a hydroxyamino acid residue on an internucleotide phosphate group.
In vitro formation of the covalent complex occurs in a two component reaction, i.e. nucleic acids and protein.
In the cell, before binding the protein recognizes all aspects of the nucleic acid structure, i.e. primary, secondary and tertiary.
In the initial stages of the reaction, the protein interacts with the nucleic acid in a cooperative mode and forms a primary non-covalent, reversible complex. The cooperative nature of primary DNA specific complex formation was shown for Topo I (57), φX174 protein A (58) and many other examples of this class of proteins. The tight (non-covalent) complex formed by Topo I and DNA (59) or the Col EI relaxation complex (60) can be dissociated in a 'high salt Mg 2+ ' solution.
Formation of a tri-substituted phosphate intermediate is possible, which could induce weakening of the adjacent internucleotide bond. Decay of this intermediate results in breakage of the internucleotide bonds on either side of the phosphorous atom. It also depends on the geometry of the phosphoester bond formed by the hydroxyamino acid residue (this was conclusively demonstrated by X-ray crystallography of the DNA-human Topo I and DNA-Cre recombinase intermediate complexes; 23, 24) . For example, in the covalent complex, eukaryotic Topo I is bound to a 3′-phosphate group (37), whereas bacterial Topo I is bound to a 5′-phosphate group (61) .
Class I proteins are enzymes which combine two activities: cleavage of an internucleotide bond and restoring its formation. They belong to the polynucleotide transferase class of enzymes. The covalent complexes are active for polynucleotide transfer to an acceptor molecule. Topo I from calf thymus forms a transient covalent linkage with DNA and reforms the internucleotide bond in the presence of Mg 2+ at 24_C (62) . It was reported that poliovirus VPg (22 amino acid residues), in a covalent complex with RNA, has RNA cleavage-joining activity (63) . However, our computer analysis (A.Barskii and Yu.Drygin, unpublished results) with the Genebee program for multiple sequence alignments revealed no similarity between poliovirus VPg or its precursor protein (3AB) and the putative active centers of φX174 protein A, Topo I or Topo II.
No energy-rich compounds are necessary for either forming the nucleic acid-protein complex nor restoring the internucleotide bond nor polynucleotide transfer to an acceptor because the interpolymeric complex itself has enough free energy to bring about such reactions. The free energy of the phosphodiester formed by uridylic acid and tyrosine is ∼10 kcal/mol (64) , an amount sufficient for internucleotide bond restoration.
It appears that cleavage of the internucleotide bond and formation of the covalent complex between nucleic acid and protein take place intramolecularly without the participation of water (23, 24, 39) .
Class I proteins form so-called relaxed complexes with nucleic acids. Denaturation of the protein in the primary complex results in nicking of the nucleotide bond and covalent binding of the protein to the nascent terminal phosphate group of the nucleic acid.
Members of this class of proteins form covalent complexes in both the cytoplasm and the nucleus of the cell.
Class II
Members of the second class of proteins do not catalyse covalent complex formation and its cleavage. Special enzymes do. For example, the DNA polymerases of bacteriophage φ29 (65) and adenovirus (66) or polio RNA polymerase (67) catalyse covalent binding of class II proteins to 5′-terminal nucleotides of their respective nucleic acids. In turn, 'unlinking' enzymes catalyse hydrolysis of interpolymeric phosphodiester bonds between picornaviral RNAs and VPgs (46) (47) (48) (49) (50) (51) (52) or between DNA and Topo I in the dead-end complex (56) .
These proteins generate long-lived covalent complexes with nucleic acids by first interacting with the 5′-terminal mononucleoside triphosphate of the nascent polynucleotide in a multi-component system. Thus, in the complexes formed, the nucleic acid is always linked to the protein by its 5′-end (reviewed in [18] [19] [20] [21] [22] .
Proteins of this class belong to the so-called terminal proteins and participate in initiation reactions during nucleic acid replication.
Energy-rich compounds supply the energy for formation of covalent complexes between Class II proteins and nucleic acids.
The compartments associated with covalent complex formation for Class II proteins are cellular membranes. Initiation of replication of nucleic acids in crude cell membrane complexes has been demonstrated repeatedly (68) (69) (70) .
One can propose that combining the protein properties of a class might be useful in predicting the 'formation-disruption' mechanisms of the respective complexes. The classification above does not pretend to be a 'final diagnosis'; the near future will show how much these proteins and their respective complexes are apart.
CELLULAR COVALENT COMPLEXES
Covalent linkage of DNA to cellular proteins involved in DNA topology changes and DNA recombination has been well documented (38, 71) .
Many bacterial plasmids (colicinogenic and sex plasmids and drug resistance factors) exist as relaxed complexes (72) . Treatment of these complexes with SDS or pronase results in relaxation of the supercoiled DNA by nicking at the origin of plasmid conjugational replication and covalent binding of the plasmid-specific protein to the 5′-phosphate group of the nick (73) . It should be noted that relaxed complex formation in bacteria depends on the physiological status of the cell (74) and is regulated by catabolite repression (75) .
It is entirely possible that many eukaryotic circular episomal DNAs can form relaxed complexes similar to those of bacterial complexes. This has been shown for the plant Ti plasmid (76) . In addition, one may readily predict that many extrachromosomal genetic elements [movable genetic elements (77) and cytoplasmic DNAs (78) ] are potential candidates for covalent binding with proteins.
According to the mechanisms of formation-disjoining of the covalent complexes, relaxation proteins belong to the class I proteins discussed above.
Natural tight, presumably covalent, complexes of eukaryotic chromosomal DNA and cellular proteins have been under intensive study since the 1980s (8, 79, 80) . There are two questions crucial to these studies: (i) what are the functions of the proteins involved?; (ii) where and how are these proteins positioned on DNA? Although the nucleotide-peptides hydrolysed by phosphodiesterases have been isolated from animal (8, 81) and plant cells (82) , identification of the proteins involved in the linkage remains obscure. Arrangement of the proteins bound to DNA has mostly been discussed in the context of the structural organization of DNA threading in chromatin (82, 83) . The precise role of covalently bound proteins in chromosomal organization is not completely understood. Another issue is what functional component of chromosomal DNA is a candidate for protein linkage? There are findings that repeated sequence elements (Alu family) are tightly linked with proteins (83) .
Summing up the data on covalent complexes of chromosomal DNA with proteins, one can say that proteins with imperfectly identified molecular characteristics and functions are bound via phosphodiester bonds with some DNA sequences (8, 80, 83) . It seems that bulk isolation of the complexes formed by different proteins makes the structural and functional analyses too complicated.
To date, a few cellular phosphodiester (presumably) complexes of RNA and protein have been characterized (84) (85) (86) (87) . The finding of a p53-5.8S rRNA covalent complex (84) is a most exciting observation. The function of this complex is presently unknown, but the multifunctional properties of this tumour suppressor protein are well known (88 and references therein).
CONCLUSIONS
The existence of a new family of nucleoproteins in which nucleic acids are covalently bound to proteins is beyond question. It should be emphasized that the structure of the complex goes hand in hand with its function and that successful studies result from examination of the structure of individual complexes where the partners were identified. To date, one can predict with certainty that the number of unknown nucleic acid-protein covalent complexes is far greater than the number of those known. The aim of this review has been to provide an overview of the biochemical approaches to be used to obtain convincing evidence regarding the covalent nature of nucleoprotein complexes being investigated now and in the future.
